Showing results 1 to 20 of 26
next >
Issue Date | Title | Author(s) |
23-Dec-2016 | Cytokine therapy-mediated neuroprotection in a Friedreich's ataxia mouse model | Kemp, KC; Cerminara, N; Hares, K; Redondo, J; Cook, AJ; Haynes, HR; Burton, BR; Pook, M; Apps, R; Scolding, NJ; Wilkins, A |
2008 | Deranged calcium signaling and neurodegeneration in spinocerebellar ataxia type 3 | Chen, X; Tang, TS; Tu, H; Nelson, O; Pook, M; Hammer, R; Nukina, N; Bezprozvanny, I |
3-Jun-2019 | Dimethyl fumarate dosing in humans increases frataxin expression: A potential therapy for Friedreich’s Ataxia | Jasoliya, M; Sacca, F; Sahdeo, S; Chedin, F; Pane, C; Brescia Morra, V; Filla, A; Pook, M; Cortopassi, G |
2012 | DNA methylation and trinucleotide repeat expansion diseases | Pook, M |
23-Mar-2022 | DNA methylation in Friedreich ataxia silences expression of frataxin isoform E | Rodden, LN; Gilliam, KM; Lam, C; Rojsajjakul, T; Mesaros, C; Dionisi, C; Pook, M; Pandolfo, M; Lynch, DR; Blair, IA; Bidichandani, SI |
19-May-2022 | A Drug Combination Rescues Frataxin-Dependent Neural and Cardiac Pathophysiology in FA Models | Abeti, R; Jasoliya, M; Al-Mahdawi, S; Pook, M; Gonzalez-Robles, C; Hui, CK; Cortopassi, G; Giunti, P |
14-Nov-2019 | Elucidation of the metabolic signature of Friedreich’s ataxia | Anjomani-Virmouni, S; Kalef-Ezra, E; Valle, A; Perry, N; Tripp, A; Agliano, A; Al-Mahdawi, S; Pook, M |
21-Nov-2018 | FAST-1 antisense RNA epigenetically alters FXN expression | Pook, M; Mikaeili, H; Sandi, M; Bayot, A; Al-Mahdawi, S |
2014 | Frataxin deficiency increases cyclooxygenase 2 and prostaglandins in cell and animal models of Friedreich's ataxia | Hayashi, G; Shen, Y; Pedersen, TL; Newman, JW; Pook, M; Cortopassi, G |
2012 | Friedreich ataxia: Investigating the relationships between mismatch repair gene expression, FXN gene expression and GAA repeat instability in human and mouse cells and tissues | Ezzatizadeh, Vahid |
14-Nov-2019 | Genotype and Phenotype Characterisation of an Enhanced Friedreich Ataxia GAA Repeat Expansion Mouse Model Fxn_null::YG8s(GAA)>800 | Anjomani-Virmouni, S; Kalef-Ezra, E; Valle, A; Kleine, P; Oggianu, C; Hannana, T; Al-Mahdawi, S; Pook, M |
2015 | Genotype and phenotype characterisation of enhanced Friedreich’s ataxia GAA repeat expansion mouse models | Anjomani Virmouni, S; Sandi, C; Ezzatizadeh, V; Sandi, M; Al-Mahdawi, S; Pook, M; Anjomani-Virmouni, S |
2013 | Genotype and phenotype characterisation of Friedreich ataxia mouse models and cells | Anjomani Virmouni, Sara |
5-Jun-2020 | HMTase Inhibitors as a Potential Epigenetic-based Therapeutic Approach for Friedreich’s Ataxia | Sherzai, M; Valle, A; Perry, N; Kalef-Ezra, E; Al-Mahdawi, S; Pook, M; Anjomani-Virmouni, S |
2-Apr-2020 | A Hybrid Model- And Memory-Based Collaborative Filtering Algorithm for Baseline Data Prediction of Friedreich's Ataxia Patients | Yue, W; Wang, Z; Tian, B; Pook, M; Liu, X |
2015 | Identification and quantification of FXN antisense transcript 1 (FAST-1) in friedreich ataxia | Sandi, Madhavi |
1-May-2015 | Identification of telomere dysfunction in Friedreich ataxia | Anjomani-Virmouni, S; Al-Mahdawi, S; Sandi, C; Yasaei, H; Slijepcevic, P; Pook, M |
10-Jun-2015 | Identification of telomere dysfunction in Friedreich ataxia. | Anjomani-Virmouni, S; Al-Mahdawi, S; Sandi, C; Yasaei, H; Giunti, P; Slijepcevic, P; Pook, M |
2012 | Interferon gamma upregulates frataxin and corrects the functional deficits in a Friedreich ataxia model | Tomassini, B; Arcuri, G; Fortuni, S; Sandi, C; Ezzatizadeh, V; Casali, C; Condò, I; Malisan, F; Al-Mahdawi, S; Pook, M; Testi, R |
2018 | Investigating Friedreich ataxia disease mechanisms and therapy | Saqlain, Saba |